Prihlásiť sa Zaregistrujte sa zadarmo

% krátkych akcií spoločnosti Edesa Biotech

Aká je hodnota metriky % krátkych akcií spoločnosti Edesa Biotech?

Hodnota metriky % krátkych akcií spoločnosti Edesa Biotech, Inc. je 2.65%

Aká je definícia metriky % krátkych akcií?



% krátkych akcií (Short % of float) je počet akcií predaných na krátko v porovnaní so všetkými akciami v obehu (float) vyjadrený v percentách.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

% krátkych akcií spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Edesa Biotech

Čomu sa venuje spoločnosť Edesa Biotech?

Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.

Firmy s metrikou % krátkych akcií podobnou spoločnosti Edesa Biotech